Belite Bio Statistics

Total Valuation

Belite Bio has a market cap or net worth of $5.23 billion. The enterprise value is $4.96 billion.

Market Cap	5.23B
Enterprise Value	4.96B

Important Dates

The last earnings date was Monday, November 10, 2025, before market open.

Earnings Date	Nov 10, 2025
Ex-Dividend Date	n/a

Share Statistics

Belite Bio has 34.89 million shares outstanding. The number of shares has increased by 8.68% in one year.

Current Share Class	n/a
Shares Outstanding	34.89M
Shares Change (YoY)	+8.68%
Shares Change (QoQ)	+9.56%
Owned by Insiders (%)	1.31%
Owned by Institutions (%)	6.75%
Float	17.34M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	19.10
P/TBV Ratio	19.10
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 34.37, with a Debt / Equity ratio of 0.00.

Current Ratio	34.37
Quick Ratio	34.17
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-3,379.40

Financial Efficiency

Return on equity (ROE) is -32.30% and return on invested capital (ROIC) is -21.84%.

Return on Equity (ROE)	-32.30%
Return on Assets (ROA)	-21.22%
Return on Invested Capital (ROIC)	-21.84%
Return on Capital Employed (ROCE)	-24.64%
Revenue Per Employee	n/a
Profits Per Employee	-$2.50M
Employee Count	25
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +123.91% in the last 52 weeks. The beta is -1.45, so Belite Bio's price volatility has been lower than the market average.

Beta (5Y)	-1.45
52-Week Price Change	+123.91%
50-Day Moving Average	103.94
200-Day Moving Average	73.42
Relative Strength Index (RSI)	70.16
Average Volume (20 Days)	252,860

Short Selling Information

Short Interest	290,232
Short Previous Month	272,936
Short % of Shares Out	1.67%
Short % of Float	n/a
Short Ratio (days to cover)	3.08

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-67.59M
Pretax Income	-62.39M
Net Income	-62.39M
EBITDA	-67.41M
EBIT	-67.59M
Earnings Per Share (EPS)	-$1.93

Full Income Statement

Balance Sheet

The company has $275.61 million in cash and $510,000 in debt, giving a net cash position of $275.10 million or $7.88 per share.

Cash & Cash Equivalents	275.61M
Total Debt	510,000
Net Cash	275.10M
Net Cash Per Share	$7.88
Equity (Book Value)	274.08M
Book Value Per Share	7.86
Working Capital	269.15M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-31.20M
Capital Expenditures	n/a
Free Cash Flow	-31.20M
FCF Per Share	-$0.89

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Belite Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-8.68%
Shareholder Yield	-8.68%
Earnings Yield	-1.19%
FCF Yield	-0.60%

Analyst Forecast

The average price target for Belite Bio is $149.00, which is -0.67% lower than the current price. The consensus rating is "Strong Buy".

Price Target	$149.00
Price Target Difference	-0.67%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2